Pharmacogenetics of warfarin: A literature review
Open Access
- 15 November 2024
- journal article
- Published by ECO-Vector LLC in Cardiosomatics
- Vol. 15 (3) , 211-220
Abstract
Warfarin is an oral indirect anticoagulant that is widely used for the prevention of thromboembolic events. Pharmacogenetic testing is the most promising approach to personalizing warfarin treatment. In this review, we aimed to summarize how the patients’ genetic predispositions affect the pharmacokinetics of warfarin, which determines the different dosing regimens for patients. To correctly interpret data in clinical settings, algorithms for selecting the optimal dosing regimen need to be developed that consider the patient’s age, sex, weight, height, health status, and genetic characteristics. These algorithms could help determine the optimal dose, enhance patient adherence to treatment, and increase the physician’s confidence in the treatment safety. Furthermore, although algorithms that consider SNPs in the CYP2C9, VKORC1, and CYP4F2 genes are more effective in predicting warfarin doses, their effectiveness varies according to race.Keywords
This publication has 42 references indexed in Scilit:
- The frequency of cytochrome 4F2 rs2108622 genetic variant and its effects on the lipid profile and complications of type II diabetes among a sample of patients in Jordan: A pilot studyProstaglandins & Other Lipid Mediators, 2023
- Safety and efficacy of direct oral anticoagulants in comparison with warfarin across different BMI ranges: A systematic review and meta-analysisAnnals of Medicine & Surgery, 2022
- Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional studyPharmacological Reports, 2021
- Genetic Factors Influencing Warfarin Dose in Black‐African Patients: A Systematic Review and Meta‐AnalysisClinical Pharmacology & Therapeutics, 2020
- Precision dosing of warfarin: open questions and strategiesThe Pharmacogenomics Journal, 2019
- Effect of CYP4F2,VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 IndividualsClinical Pharmacology & Therapeutics, 2018
- Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of HemorrhagePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2018
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 UpdateClinical Pharmacology & Therapeutics, 2017
- Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian PatientsClinical Pharmacology & Therapeutics, 2008
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinClinical Pharmacology & Therapeutics, 2008